I'd like to think the 250k seller will achieve his sale late today or perhaps in early trading tomorrow .....lol.
Printable View
I'd like to think the 250k seller will achieve his sale late today or perhaps in early trading tomorrow .....lol.
Somebody bought 20k shares @ 58cents from a limit seller during the AGM and no other sellers nor additional sell-side depth built during this time so that's better than nothing :)
if you look at the depth - the way they are stacked up looks like a lighthouse - is this an omen:eek2::eek2::scared::)
on the sell side
True - but now there's a seller at 135!
Pacific Edge didn't present anything particularly new at the AGM. No sales guidance past the 100mil 5 year target. Darling did talk about a collection of urologists they "expected to bring on board soon" in the US.
Its just all systems go really, Darling responded to a question about sales staff that he expected to have 20 sales staff in the US alone when things hit "full noise."
Will have a better expectation of where they are on the growth curve by the end of the year.
Cheers.
Thanks Andy, nothing to send price skyrocketing yet, steady as she goes.
Meeting got off to slow start,
was packed small seminar room had to bring in extra seats at last moment.
No sound on PowerPoint, 20 mins of waiting for sound. almost felt sorry for them.
No new news, recap of year, outlook good but no sales / numbers yet. Cranking up US sales force etc.
2014 will be the year, End of 2013 should have produced initial US sales.
Talking to more DHB's who see CX as way of saving money by its being more accurate and cheaper than full clinical testing they do now on suspected cases .
I like PEB story just need to see some sales before I invest any more in their potential, definitely not selling.
ODT reporter / photog there so check tomorrows ODT for more detail.
thanks for the information guys and guyesses- anything re nz aus or spain sales?
I agree, there was no substantially new news from what has previously been presented. It seemed to be an AGM for providing confidence, and I thought that the sales strategy presented earlier in the year was confidently affirmed.
There we're four hybrid products of cxbladder presented to accommodate 8 prospective applications up from 4 identified earlier in 2012.
David Darling advised that PEB are still "on track" in meeting the $100M rev target in year five. He reaffirmed his previous position that we will receive sales advice "later in the year".
He stressed the high revenue margins per sale and said it was just a matter of getting lots of tests performed. He also suggested though that the US price point may be US$550 which I understand to be at the lower end of the previously advised range of 550 to 630, I've used 550 in my modelling so no impact for me.
I was left with no specific reason to doubt that PEB will go forth as planned.
I'm looking forward to the half year report now and suspect that the market may now start to price in the forward sales curve as we approach HY14 reporting in 3 months time.
As others have mentioned things seem to be on track. David Darling commented that signing up one of the big US lugs could be a big change for the company.
Hopefully they sign one up soon, plus some more DHB 's.
Some interesting comment regarding any possible takeover bid. Defiantly not signalled but I got the impression that if one did come it would not be a total suprise.
I will wait for my buy then :D, no hurry to get in at the moment.
Thanks so much guys!!!
David Darling explained that each US LUG was larger than all the NZ DHB's combined, he seemed genuinely excited by the prospect of a LUG sign up, anyone recall his exact words, it would be a 'ground shaker' or something.
Anyway, I guess that it could happen at any time, but his sudden burst of energy whilst he was explaining it made me consider that it could possibly be sooner rather than later ?.
thanks to everyone for the detailed feedbacks - almost like being there:)
Hancocks,
For one who doesn't post a lot, you always write something worthwhile reading! Thank you for a comprehensive report on today's meeting.
Like you, I am comfortable with David Darling not giving financial projections, with the nature of this business in particular, perhaps the less made public, the better.
If discussions at the AGM were not doom and gloom then just keep doing what you're doing.
Well guys ,with all due respect ,after the big ramp up to the AGM its still ''steady as she goes"
I believe this is a good company but personally think the 'getting ready to take off like a rocket' is not the case here,...anymore.IMHO its will be a slow process,until hopefully it will finally get to a slow,but good growth phase.
After the initial ''take off'' phase driven by projected potential it certainly appears to be settling in for the long haul.Everyone would like to see another Ryman Health type chart and heres hoping,but patience is virtue as they say.
0 to $100m in Revenue in 5 years isn't exactly slow. Would almost compete with XRO if you ignore all the years it's taken them to get started.
The only difference in my mind is XRO is lead by an entrepreneur/salesman and the other is lead by conservative scientists.
It they do sign up an American health Board, its all go.